Rubén Queiro

Associate Professor

University of Oviedo

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rubén Queiro is an Associate Professor at the University of Oviedo in Spain. His research focuses on inflammatory biomarkers in spondyloarthritis and psoriatic arthritis, exploring topics such as treatment pathways, patient-specific strategies, and quality of life assessments. He has contributed to the field through various recent publications, including studies on the performance of disease activity indices and the validation of assessment questionnaires.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Annette van der Helm - van Mil

Full Professor

Erasmus MC

NETHERLANDS

View details

Ernest Choy

Professor of Rheumatology

Cardiff University

UNITED KINGDOM

View details

Eliecer Coto

SPAIN

View details

Alen Zabotti

ITALY

View details

Paolo Gisondi

University of Verona

ITALY

View details

Laure Gossec

FRANCE

View details

Stefan Siebert

Professor of Inflammation Medicine and Rheumatology

University of Glasgow

UNITED KINGDOM

View details

Marta Loredo

Central University Hospital of Asturias

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rubén Queiro

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Drs. Queiro and Braña reply

Reassessing traditional inflammatory biomarkers in spondyloarthritis: time for a paradigm shift?

Understanding the Psoriasis Phenotype Associated With Psoriatic Arthritis Using the PURE-4 Questionnaire: Insights From Spanish Real-World Settings

Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles

Navigating Psoriatic Arthritis: Treatment Pathways and Patient-Specific Strategies for Improved Outcomes

Dose Tapering of Advanced Therapies in Psoriatic Arthritis: Clinical Predictors and Outcomes in a Biosimilar-Dominant Real-Life Cohort

The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of life

Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up

Performance of Disease Activity Indices Used in Axial Spondyloarthritis in Real-World Clinical Settings

Early axial spondyloarthritis versus established disease: a single-center analysis based on the new ASAS definition of early disease

Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

The nail in psoriatic arthritis: new insights into prognosis and treatment

Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

Patients With Psoriatic Arthritis–Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions

Psoriatic nail complex: thick as thieves

In the search for an accurate and early diagnosis of psoriatic arthritis: is the key in ultrasound?

HLA-C*06–defined endotype in psoriatic disease: an ever-widening landscape

How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

Ultrasound in Psoriatic Arthritis: Still Many Pending Issues

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.

Managing psoriatic arthritis in different clinical scenarios

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.

Interleukin-17-targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile.

Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?

Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?

Osteomalacia in Adults: A Practical Insight for Clinicians

Comment on: Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen

Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

Collaborators (8)

Annette van der Helm - van Mil

Ernest Choy

Eliecer Coto

Alen Zabotti

Paolo Gisondi

Laure Gossec

Stefan Siebert

Marta Loredo

Make your next move.